Metraipolis › archive › dc_375377dce667

Serum advanced glycation end-products as a biomarker of cumulative glycaemic burden and complications in type 2 diabetes: a pilot study — Europe PMC PMID:42159221

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42159221
DOI
10.1080/07853890.2026.2671517
License (as archived)
solo-consultazione
Archived
2026-11-01T10:42:43.763Z
SHA-256 of the archived text
3f3743cad156510916e35f3d69e748c540ce34a3c7dd37c8f6f1c3e5a49cc6a1
Stable URL of this page
https://metraipolis.com/documento/dc_375377dce667

How to cite

Serum advanced glycation end-products as a biomarker of cumulative glycaemic burden and complications in type 2 diabetes: a pilot study — Europe PMC PMID:42159221 — Europe PMC (en), https://europepmc.org/article/MED/42159221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_375377dce667 (Metraipolis archive dc_375377dce667, sha256 3f3743cad156510916e35f3d69e748c540ce34a3c7dd37c8f6f1c3e5a49cc6a1)
BibTeX
@misc{dc375377dce667,
  title = {Serum advanced glycation end-products as a biomarker of cumulative glycaemic burden and complications in type 2 diabetes: a pilot study — Europe PMC PMID:42159221},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42159221},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_375377dce667; sha256 3f3743cad156510916e35f3d69e748c540ce34a3c7dd37c8f6f1c3e5a49cc6a1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42159221. Agents can read the archived copy with the MCP tool read_document.